The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: infliximab     Quarter: 2016Q3

Total Records: 643     Number of Pages: 33

DRUGNAME PT EventCount
INFLIXIMAB Joint injury 1
INFLIXIMAB Laceration 1
INFLIXIMAB Lactose intolerance 1
INFLIXIMAB Live birth 1
INFLIXIMAB Loss of consciousness 1
INFLIXIMAB Lung neoplasm malignant 1
INFLIXIMAB Lymphadenopathy mediastinal 1
INFLIXIMAB Lymphoma 1
INFLIXIMAB Malabsorption 1
INFLIXIMAB Meningitis cryptococcal 1
INFLIXIMAB Migraine 1
INFLIXIMAB Muscle spasms 1
INFLIXIMAB Muscular weakness 1
INFLIXIMAB Musculoskeletal stiffness 1
INFLIXIMAB Mydriasis 1
INFLIXIMAB Nail disorder 1
INFLIXIMAB Neoplasm malignant 1
INFLIXIMAB Neutropenia 1
INFLIXIMAB Obstructive airways disorder 1
INFLIXIMAB Onychomycosis 1

Total Records: 643     Number of Pages: 33